Washington: Healthy pregnant women tend to develop a strong immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial.Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, the trial involved a preliminary analysis of blood samples taken 21 days post-vaccination from a subgroup of 50 pregnant women."For pregnant women, who are among the most vulnerable to serious health problems from 2009 H1N1 infection, these initial results are very reassuring," said NIAID Director Dr. Anthony S Fauci.
The two injections of vaccine are spaced three weeks apart. Safety is being monitored closely in the trial, by the study investigators and by an independent panel of experts known as a safety monitoring committee.To date, the vaccine appears to be well tolerated, and no safety concerns related to the vaccine have arisen. ANI
Smriti Irani files nomination from Amethi
Srinivasan should be kept out of BCCI affairs: SC
61st National Film Awards announced
Ananth Kumar calls Congress a non-performer across India